Clinical Trial Update: Circulating Tumor DNA (ctDNA) in Locally Advanced Esophageal and Gastroesophageal (GE) Junction Adenocarcinoma

View source ↗

Summary

A clinical trial evaluating circulating tumor DNA in locally advanced esophageal and gastroesophageal junction adenocarcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Adenocarcinoma Esophagus | Status: WITHDRAWN